After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April
Here is how: Go to andel.org/referral Fill out the Refer Your Company form Let Andel reach out to them directly It takes 5 minutes to hand your employer a vetted Lilly partner with transparent pricing, no administrative overhead, and a cost structure that is cheaper than traditional insurance
Patients should ask their provider which ingredient form is being used
Then theres tirzepatide (Mounjaro, Zepbound), a newer medication that not only targets GLP-1 but also GIP receptors, and studies show it may deliver even greater weight loss results and metabolic benefits
Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable or oral medications used to manage type 2 diabetes and obesity in the UK
We want to emphasize that although these factors can be used to guide clinical decisions, they may not have a causal relationship with the response to GLP-1 M